Simplex Trading’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$335K Buy
9,200
+600
+7% +$18.9K ﹤0.01% 4101
2026
Q1
$241K Buy
+8,600
New +$282K ﹤0.01% 4076
2025
Q4
Sell
-9,100
Closed -$250K 9190
2025
Q3
$250K Buy
9,100
+7,500
+469% +$258K ﹤0.01% 4677
2025
Q2
$50K Buy
1,600
+800
+100% +$25.7K ﹤0.01% 5916
2025
Q1
$26K Sell
800
-200
-20% -$7.17K ﹤0.01% 6363
2024
Q4
$34K Buy
1,000
+400
+67% +$13.7K ﹤0.01% 6237
2024
Q3
$24K Sell
600
-15,700
-96% -$551K ﹤0.01% 6528
2024
Q2
$491K Sell
16,300
-9,700
-37% -$292K ﹤0.01% 3687
2024
Q1
$873K Buy
26,000
+23,200
+829% +$745K ﹤0.01% 3261
2023
Q4
$90K Sell
2,800
-3,700
-57% -$103K ﹤0.01% 5492
2023
Q3
$213K Buy
6,500
+1,100
+20% +$38.2K ﹤0.01% 4277
2023
Q2
$190K Sell
5,400
-1,400
-21% -$48.3K ﹤0.01% 4349
2023
Q1
$222K Buy
6,800
+5,600
+467% +$255K ﹤0.01% 4198
2022
Q4
$66K Buy
1,200
+1,100
+1,100% +$60.5K ﹤0.01% 5535
2022
Q3
$4K Hold
100
﹤0.01% 8913
2022
Q2
$4K Buy
+100
New +$4.5K ﹤0.01% 8972

Other funds holding HRMY

Simplex Trading's HRMY Position: Q2 2026 in Review

Simplex Trading opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 360 shares worth $13.1K. The stake represents ﹤0.01% of the portfolio and ranks #7468 among its holdings. This is a return to the name: Simplex Trading previously reported a position in HRMY as recently as Q3 2025.

Simplex Trading first reported a position in HRMY in Q1 2022 and has held it in 8 quarters since. The position peaked at $168K in Q2 2024. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Simplex Trading held 360 shares of Harmony Biosciences worth $13.1K as of Q2 2026.
  • Harmony Biosciences was a new Simplex Trading position in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7468 holding.
  • Simplex Trading first reported a position in Harmony Biosciences in Q1 2022 and has held it in 8 quarters since.
  • Simplex Trading's Harmony Biosciences position peaked at $168K in Q2 2024.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.